Nextcure, Inc.

Biotechnology • Healthcare • Beltsville, MD, United States • NXTC (NMS)

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

NextCure Launches At-The-Market Stock Offering Program - TipRanks

TipRanks • Dec 19

NextCure Raises $21.5M to Extend Runway and Advance ADC Programs - BioBuzz

BioBuzz • Nov 12

Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect? - Yahoo Finance

Yahoo Finance • Nov 11

NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules - GlobeNewswire

GlobeNewswire • Nov 12

NextCure (NASDAQ: NXTC) announces $21.5M private placement to extend runway into 2027 - Stock Titan

Stock Titan • Nov 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has NextCure, Inc. had layoffs?

No layoff events have been recorded for NextCure, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does NextCure, Inc. have?

NextCure, Inc. has approximately 43 employees.

What industry is NextCure, Inc. in?

NextCure, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is NextCure, Inc. a publicly traded company?

Yes, NextCure, Inc. is publicly traded under the ticker symbol NXTC on the NMS. The company has a market capitalization of approximately $0.04 billion.

Where is NextCure, Inc. headquartered?

NextCure, Inc. is headquartered in Beltsville, MD, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.